Skip to Main Content

Paper Details

Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection or Hospitalization: A Cohort Study.
Am J Hypertens
27
2021
Aldosterone, Angiotensin-converting enzyme, COVID-19, COVID-19 Infection, COVID-19 infection, DDDs, Renin, angiotensin receptor, coronavirus disease 2019, obesity, people
Author NameAffiliation
Rod L WalkerKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington
James S FloydKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington
James S FloydCardiovascular Health Research Unit, University of Washington
James S FloydUniversity of Washington
James S FloydKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington
James S FloydUniversity of Washington
James S FloydCardiovascular Health Research Unit, University of Washington
Susan M ShortreedKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington
Susan M ShortreedUniversity of Washington
Susan M ShortreedKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington
Susan M ShortreedUniversity of Washington
Bruce M PsatyUniversity of Washington
Bruce M PsatyCardiovascular Health Research Unit, University of Washington
Bruce M PsatyDepartment of Health Services, University of Washington
  • 1 - 14

Datasets

Release 1.2